One Foot In A Science Lab, The Other In Big Business

ENTREPRENEURIAL SCIENCE: New Links Between Corporations, Universities, And Government Robert F. Johnston and Christopher G. Edwards; Greenwood Press; Westport, Conn.; 157 pages; $37.95 Government policy makers often argue that the reason for United States industries’ failure to sustain their top standing in the world marketplace lies not in the absence of exciting new technologies developed in our research laboratories, but rather in the sluggish rate of technology transfer from those

Written byDavid Kingsbury
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ENTREPRENEURIAL SCIENCE: New Links Between Corporations, Universities, And Government

Robert F. Johnston and Christopher G. Edwards; Greenwood Press;
Westport, Conn.;
157 pages; $37.95

Government policy makers often argue that the reason for United States industries’ failure to sustain their top standing in the world marketplace lies not in the absence of exciting new technologies developed in our research laboratories, but rather in the sluggish rate of technology transfer from those laboratories to our major industries. In this thought-provoking volume, the authors attempt to lead the readers into a vision of the year 2000, when a new order enhances technology transition.

The mechanism for this new order is a generation of highly innovative entrepreneurial companies with one foot in the universities and the other in the board rooms of multinational corporations. To some readers this will sound naive and unrealistic; to others it will sound like the biotechnology industry that already ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies